Skip to main content
SpringerLink
Log in

Drug and Gene Electrotransfer in Cancer Therapy

  • Chapter
  • First Online:
Somatic Genome Manipulation

Abstract

Drug and gene delivery by electroporation is gaining increasing momentum, in particular delivery of chemotherapeutic agents (electrochemotherapy) is now routinely used in many cancer centers, and gene therapy is in clinical trials. Gene therapy using electrotransfer offers the possibility to create a localized area hosting the transgene, with possibility for (1) local effects on tumors, (2) systemic effect through local activation of the immune system, or (3) local production of the transgenic protein followed by secretion to the systemic circulation, where these drugs may exert desired effects on cancer cells, and/or on supportive structures such as blood vessels. An increasing amount of knowledge is accumulating on important pathways for cancer progression, and this allows discovery of new targets for cancer therapy. Gene therapy offers an easier and less expensive strategy for therapy, since DNA may be produced more easily than formulation of protein drugs, enabling a higher level of access to new potential drugs. Many cancer gene therapy clinical trials are ongoing at this time, and it will be very interesting to follow the clinical results. This chapter reviews the progress in drug and gene electrotransfer, describes the details of the procedure, as well as offers the perspectives for this technology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, Gehl J (2011) Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 71:3753–3762

    Article  CAS  PubMed  Google Scholar 

  • Altshuler D, Durbin R M, Abecasis GR, Bentley DR, Chakravarti A, Clark AG, Collins FS et al (2010) A map of human genome variation from population-scale sequencing. Nature 467:1061–1073

    Article  PubMed  Google Scholar 

  • Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72:3694–3700

    Article  CAS  PubMed  Google Scholar 

  • Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D (2000) Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 1474:353–359

    Article  CAS  PubMed  Google Scholar 

  • Collins FS, Lander ES, Rogers J, Waterston RH (2004) Finishing the euchromatic sequence of the human genome. Nature 431:931–945

    Article  Google Scholar 

  • Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL, Heller R (2008a) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26:5896–5903

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster P N, Sullivan DM, Ugen KE, Messina JL, Heller R (2008b) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26:5896–5903

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Draghia-Akli R, Pope MA, Brown PA, Khan AS (2006) Plasmid-based expression technology using growth hormone releasing hormone: a novel method for physiologically stimulating long-term growth hormone secretion. Comb Chem High Throughput Screen 9:181–185

    Article  CAS  PubMed  Google Scholar 

  • Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, Mali B, Jarm T, Pavliha D, Marcan M, Gasljevic G, Gorjup V, Music M, Vavpotic TP, Cemazar M, Snoj M, Sersa G (2011) Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treatment 10:475–485

    CAS  Google Scholar 

  • Ferraro B, Cruz YL, Coppola D, Heller R (2009) Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing. Mol Ther 17:651–657

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fini M, Tschon M, Ronchetti M, Cavani F, Bianchi G, Mercuri M, Alberghini M, Cadossi R (2010) Ablation of bone cells by electroporation. J Bone Joint Surg Br 92:1614–1620

    Article  CAS  PubMed  Google Scholar 

  • Gaylor DC, Prakah-Asante K, Lee RC (1988) Significance of cell size and tissue structure in electrical trauma. J Theor Biol 133:223–237

    Article  CAS  PubMed  Google Scholar 

  • Gehl J (2003) Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 177:437–447

    Article  CAS  PubMed  Google Scholar 

  • Gehl J (2005) Investigational treatment of cancer using electrochemotherapy, electrochemoimmunotherapy and electro-gene transfer. Ugeskr Laeger 167:3156–3159

    PubMed  Google Scholar 

  • Gehl J, Skovsgaard T, Mir LM (1998) Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 9:319–325

    Article  CAS  PubMed  Google Scholar 

  • Gehl J, Sørensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T, Mir LM (1999) In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1428:233–240

    Article  CAS  PubMed  Google Scholar 

  • Gehl J, Skovsgaard T, Mir LM (2002) Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 1569:51–58

    Article  CAS  PubMed  Google Scholar 

  • Glass LF, Fenske NA, Jaroszeski M, Perrott R, Harvey DT, Reintgen DS, Heller R (1996) Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 34:82–86

    Article  CAS  PubMed  Google Scholar 

  • Golzio M, Teissie J, Rols MP (2002) Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci U S A 99:1292–1297

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gothelf A, Gehl J (2010) Gene electrotransfer to skin; review of existing literature and clinical perspectives. Current Gene Ther 10:287–299

    Article  CAS  Google Scholar 

  • Gothelf A, Gehl J (2011) Gene electrotransfer to skin. In Kee S, Gehl J, Lee E (eds) Clinical aspects of electroporation pp 189–202. Springer, New York

    Chapter  Google Scholar 

  • Gothelf A, Hojman P, Gehl J (2010) Therapeutic levels of erythropoietin (EPO) achieved after gene electrotransfer to skin in mice. Gene Ther 17:1077–1084

    Article  CAS  PubMed  Google Scholar 

  • Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G et al (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153–158

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Heller R, Jaroszeski M J, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, Glass LF (1998) Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 83:148–157

    Article  CAS  PubMed  Google Scholar 

  • Hojman P, Gissel H, Gehl J (2007) Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation. Gene Ther 14:950–959

    Article  CAS  PubMed  Google Scholar 

  • Hojman P, Spanggaard I, Olsen CH, Gehl J, Gissel H (2011) Calcium electrotransfer for termination of transgene expression in muscle. Hum Gene Ther 22:753–760

    Article  CAS  PubMed  Google Scholar 

  • Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R (2000) Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 11:201–208

    Article  CAS  PubMed  Google Scholar 

  • Joergensen M, Agerholm-Larsen B, Nielsen PE, Gehl J (2011) Efficiency of cellular delivery of antisense peptide nucleic acid by electroporation depends on charge and electroporation geometry. Oligonucleotides 21:29–37

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kotnik T, Miklavcic D (2000) Analytical description of transmembrane voltage induced by electric fields on spheroidal cells [In Process Citation]. Biophys J 79:670–679

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Limaye SA, Posner MR, Krane JF, Fonfria M, Lorch JH, Dillon DA, Shreenivas AV, Tishler RB, Haddad RI (2013) Trastuzumab for the treatment of salivary duct carcinoma. Oncologist 18:294–300

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Linnert J, Gehl J (2009) Bleomycin treatment of brain tumors. An evaluation. Anticancer Drugs 20:157–164

    Article  CAS  PubMed  Google Scholar 

  • Linnert M, Iversen HK, Gehl J (2012) Multiple brain metastases—current management and perspectives for treatment with electrochemotherapy. Radiol Oncol 46:271–278

    Article  PubMed Central  PubMed  Google Scholar 

  • Mahmood F, Gehl J (2011) Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. Bioelectrochem 81:10–16

    Article  CAS  Google Scholar 

  • Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D, Pavlovic I, Paulin-Kosir SM, Cemazar M, Morsli N, Rudolf Z, Robert C, O’Sullivan GC, Mir LM (2006) Electrochemotherapy—an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Ejc Suppl 4:3–13

    Article  CAS  Google Scholar 

  • Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC, Bond JE, Muir T, Gehl J (2011) Management of cutaneous metastases using electrochemotherapy. Acta Oncol 50:621–629

    Article  PubMed Central  PubMed  Google Scholar 

  • Matthiessen LW, Johannesen HH, Hendel HW, Moss T, Kamby C, Gehl J (2012) Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncologica 51:713–721

    Article  PubMed  Google Scholar 

  • Miklavcic D, Sersa G, Brecelj E, Gehl J, Soden D, Bianchi G, Ruggieri P, Rossi CR, Campana LG, Jarm T (2012) Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 50:1213–1225

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B, Scherman D (1999a) High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 96:4262–4267

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud J-M, Delaere P, Branellec D, Schwartz B, Scherman D (1999b) High efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 96:4262–4267

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mir LM, Moller PH, Andre F, Gehl J. (2005) Electric pulse-mediated gene delivery to various animal tissues. Adv Genet 54:83–114

    Article  CAS  PubMed  Google Scholar 

  • Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, Geertsen PF, Rudolf Z, O’Sullivan GC, Marty M (2006) Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 4:14–25

    Article  CAS  Google Scholar 

  • Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841–845

    PubMed Central  CAS  PubMed  Google Scholar 

  • Neumann E, Kakorin S, Tsoneva I, Nikolova B, Tomov T (1996) Calcium-mediated DNA adsorption to yeast cells and kinetics of cell transformation by electroporation. Biophys J 71:868–877

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Orlowski S, Belehradek J Jr, Paoletti C, Mir LM (1988) Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37:4727–4733

    Article  CAS  PubMed  Google Scholar 

  • Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JKV, Gazdar AF, Hartigan J, Wu L, Liu CS, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274

    Article  PubMed  Google Scholar 

  • Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New Engl J Med 344:783–792

    Article  CAS  PubMed  Google Scholar 

  • Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Tamas P, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J (2011) Adjuvant Trastuzumab in HER2-positive breast cancer. New Engl J Med 365:1273–1283

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Spanggaard I, Corydon T, Hojman P, Gissel H, Dagnaes-Hansen F, Jensen TG, Gehl J (2012) Spatial distribution of transgenic protein after gene electrotransfer to porcine muscle. Hum Gene Ther Methods 23:387–392

    Article  CAS  PubMed  Google Scholar 

  • Spanggaard I, Snoj M, Cavalcanti A, Bouquet C, Sersa G, Robert C, Cemazar M, Dam E, Vasseur B, Attali P, Mir L, Gehl J (2013) Gene electrotransfer of plasmid AMEP in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Hum Gene Ther Clin Dev 24:99–107. (In Press)

    Article  CAS  PubMed  Google Scholar 

  • Staal LG, Gilbert R (2011) Generators and applicators: equipment for electroporation. In Kee S, Gehl J, Lee E (eds) Clinical aspects of electroporation pp. 45–65. Springer, New York

    Chapter  Google Scholar 

  • Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, Mcvie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, HirschBR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M (2011) Delivering affordable cancer care in high-income countries. Lancet Oncol 12:933–980

    Google Scholar 

  • Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KMW, Putnam JB, Richli WR, Savin M, Schrump DS, Shin DM, Shulkin A, Walsh GL, Wait J, Weill D, Waugh MKA (1999) Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Nat Cancer Inst 91:763–771

    Article  CAS  PubMed  Google Scholar 

  • Vaughan EE, Dean DA (2006) Intracellular trafficking of plasmids during transfection is mediated by microtubules. Mol Ther 13:422–428

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Whelan MC, Larkin JO, Collins CG, Cashman J, Breathnach O, Soden DM, O’Sullivan GC (2006) Effective treatment of an extensive recurrent breast cancer which was refractory to multimodal therapy by multiple applications of electrochemotherapy. Ejc Supplements 4:32–34

    Article  Google Scholar 

  • Ziegler MJ, Vernier PT (2008) Interface water dynamics and porating electric fields for phospholipid bilayers. J Phys Chem B 112:13588–13596

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The author is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Acta Oncologica Foundation.

Author information

Authors and Affiliations

  1. Center for Experimental Drug and Gene Electrotransfer, Department of Oncology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, 2730, Herlev, Denmark

    Dr. Julie Gehl MD, Dr. Med Sci

Authors
  1. Dr. Julie Gehl MD, Dr. Med Sci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie Gehl MD, Dr. Med Sci .

Editor information

Editors and Affiliations

  1. Potato Research Centre, Agriculture and Agri-Food Canada, Government of Canada, Fredericton, New Brunswick, Canada

    Xiu-Qing Li

  2. Plant Science Department, McGill University, Sainte-Anne-de-Bellevue, Québec, Canada

    Danielle J. Donnelly

  3. Department of Biomedicine, Aarhus University, Herning, Denmark

    Thomas G. Jensen

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Gehl, J. (2015). Drug and Gene Electrotransfer in Cancer Therapy. In: Li, XQ., Donnelly, D., Jensen, T. (eds) Somatic Genome Manipulation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2389-2_1

Download citation

Publish with us

Policies and ethics

Search

Navigation